相关实验视频

Updated: May 24, 2025

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

通过4-基酸调节α-Synuclein动和毒性

Kristos Baffour¹, Neelima Koti¹, Tony Nyabayo¹

¹Department of Chemistry and Biochemistry, Missouri State University, 901 S. National Avenue, Springfield, Missouri 65897, United States of America.

ACS chemical neuroscience

|February 28, 2025

概括

在帕金森病模型中,4-基酸盐 (PBA) 降低了有毒的α-synuclein (α-Syn) 聚合. PBA与α-Syn寡合体相互作用,降低神经毒性并改变聚合动力学,提供潜在的疾病修饰干预措施.

科学领域:

神经科学是一个神经科学.
生物化学生化学
分子生物学分子生物学

背景情况:

蛋白质错误折叠和α-synuclein (α-Syn) 的聚合是帕金森病 (PD) 发病的核心原因.
4-丁酸盐 (PBA) 是一种潜在的化学伴侣,但其向α-Syn聚合的机制尚不清楚.

研究的目的:

阐明4-甲基 (PBA) 在调节α-synuclein (α-Syn) 聚合中的分子机制及其对神经毒性的影响.

主要方法:

在体外测试包括蛋白酶K (PK) 测试,表面等离子体共振 (SPR),尼罗河红色测试,细胞毒性测试和基于黄素T的测试.
用分子动力学 (MD) 模拟来研究PBA与α-Syn寡合物的相互作用.

主要成果:

PBA处理改变了α-Syn聚合模式,减少了寡合物种,增加了对蛋白质分解裂变的敏感性.
PBA与α-Syn寡合体中的疏水接触相互作用,显著降低了α-Syn-amyloid诱导的毒性.
PBA加速α-Syn粉样纤维的形成,并使α-Syn寡合体的C端不稳定.

结论:

通过准α-Syn错误折叠和聚合,PBA表现出神经保护潜力.
PBA的机制涉及与α-Syn寡合体的直接相互作用,减少毒性并影响聚合动力学.
这些发现表明PBA是帕金森病和其他神经退行性疾病的潜在治疗策略.

关键词:

4 - 基酸是什么? 4-基酸是什么?粉样蛋白质是一种粉样蛋白质.分子动力学模拟,分子动力学模拟寡合物是指一些寡合物.的α-synuclein纤维化发生.

更多相关视频

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...